delta-Valerolactone | CAS:542-28-9

We serve delta-Valerolactone CAS:542-28-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
delta-Valerolactone

CAS No: 542-28-9
Product Name: δ-Valerolactone
Other Name:
δ-Valerolactone
delta-Valerolactone
5-valerolactone
Tetrahydro-2H-pyran-2-one
Tetrahydro-2-pyranone
 
Density: 1.1±0.1 g/cm3
Boiling Point: 218.0±8.0 °C at 760 mmHg
Melting Point: -13 °C
Molecular Formula: C5H8O2
Molecular Weight: 100.116
Flash Point: 100.0±0.0 °C
Exact Mass: 100.052429
PSA: 26.30000
LogP: -0.20
Vapour density: 3.45 (vs air)
Vapour Pressure: 0.1±0.4 mmHg at 25°C
Index of Refraction: 1.440
Storage condition: 2-8°C
Water Solubility: miscible
 
Specification
Appearance: Colorless to light yellow transparent liquid
Assay: ≥99.0%
Water: ≤0.10%
 
Application
δ-Valerolactone is a lactone used as a chemical intermediate in processes such as the production of polyesters.
Applicationd in flavors and fragrances, pharmaceutical intermediates.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.



Contact us for information like delta-Valerolactone chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Tetrahydro-2-pyranone physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Tetrahydro-2-pyranone Use and application,delta-Valerolactone technical grade,usp/ep/jp grade.


Related News: We are pleased that intravenous rigosertib will be made compliantly available to suitable patients with higher-risk MDS through their physicians in designated countries.methyl methacrylate manufacturer In addition, a high-standard GMP workshop is under construction and is expected to be put into production within the year. As the capacity bottleneck is broken, the pharmaceutical intermediate business is expected to grow rapidly in the future, providing the company with new growth momentum.1-(bromomethyl)-2-(trifluoromethyl)benzene supplier In addition, a high-standard GMP workshop is under construction and is expected to be put into production within the year. As the capacity bottleneck is broken, the pharmaceutical intermediate business is expected to grow rapidly in the future, providing the company with new growth momentum.naphthalen-1-yl carbonochloridate vendor “Standard respiratory support therapies are used to treat the symptoms and wait for the virus to be cleared by itself.””Standard respiratory support therapies are used to treat the symptoms and wait for the virus to be cleared by itself.”